Global Deep Brain Stimulation Devices Revenue Is Nearly 720 Million USD In 2016
Wednesday, 24 Oct, 2018
In the last several years, global market of Deep Brain Stimulation Devices developed rapidly, with an average growth rate of 11.8 %. In 2016, global revenue of Deep Brain Stimulation Devices is nearly 720 million USD; the actual production is about 30900 units.
The classification of Deep Brain Stimulation Devices includes Single-channel?DBS and Dual?Channel?DBS, and the revenue proportion of Single-channel?DBS in 2016 is about 45.2%. Deep Brain Stimulation Devices can be used for Parkinson’s disease, Essential?Tremor, Dystonia and other. The most proportion of Deep Brain Stimulation Devices is used for Parkinson’s disease, and the sales proportion is about 77.4% in 2016. Increasing prevalence of neurological disorders is one of the critical factors driving the growth of this (DBS) deep brain stimulation market globally.
North America is the largest sales place, with a sales market share nearly 51% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 30%. China, Japan is also important sales regions for Deep Brain Stimulation Devices.
Deep Brain Stimulation Device market is mainly occupied by large companies, Sorin as the largest player in the market produced over 57% of Artificial Heart Lung Machine and made more than 59.6% of revenue share in 2016. MAQUET followed as second produced about 18.3% in 2016.
Through the above research we tend to believe that Medtronic is the most important player in the market and it will occupy a major share of the market with about 70%. The competition will become more intense, companies will play more and more attention to developing regions in the future. Most DBS systems have received CE mark in Europe and then received approval in the US. Frequent approvals by regulatory services boost the market growth. The rise in the number of products seeking approval may help the market grow at a rapid pace during the forecast period.